An underground economy for unlicensed weight-loss medications is propelled by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Experimental Drug Gaining Popularity Via Social Media
Retatrutide, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Viewers are urged to contact these profiles directly for source information, while also obtaining discount codes.
Active Trade on Social Networks
Separately, a robust trade exists on Telegram, where communities with thousands of participants share “before and after” images, administration instructions and claims of next-day British shipping. Sellers promote the drug there before directing buyers to WhatsApp for transactions.
Understanding Retatrutide
Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.
Medical Professionals Voice Worries
However, doctors and pharmacists have warned that the distribution of what remains an unlicensed medication in the UK is worrisome and could lead to users administering products of uncertain source.
Several experts stated the demand for the experimental drug could be connected to the rising cost of approved slimming products such as Mounjaro.
Regulatory Position and Enforcement
Selling the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be marketed or supplied for personal consumption under the British medical regulations.
Some influencers try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach pharmaceutical, marketing, and customer regulations, risking fines, legal action or prison.
Service Response and Content Elimination
Based on TikTok, the platform has taken down violative content and banned related keywords and query recommendations. The company stated it was dedicated to keeping the platform secure and investing in strengthening compliance measures.
Online Marketplace Operations
Research also found groups with up to nine thousand participants marketing the experimental drug using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly brings up groups with numerous of members, filled with photos of weight loss, positive reviews and step-by-step guides for preparing or administering at home.
Within moments of entering one community, a seller shared contact information, where most transactions take place. The vendor provided an instruction manual and promised delivery within two days. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about weight, medical conditions or previous experience.
Product Information and Pricing
Inside these groups, posts display dark colored packages with postal service labels, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with sterile water, or pre-filled injectors typically sold at £160 for 20mg. When asked how much time a injector should last, sellers give conflicting answers varying between a several days to “depends on your body”.
Service Moderation and Security Measures
A spokesperson for the messaging service said it actively monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are administering substances they cannot confirm. Even if the research behind retatrutide is sound, these digital versions may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent cost increases for approved slimming medications such as Mounjaro. “With costs rising, patients are using online platforms. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she said.
Her team has already encountered individuals harmed by personal administration from unverified sources. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Position
A representative from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject users to possibly serious medical dangers”.
